Journal profile · Peripheral Vascular Disease
Journal of Thrombosis and Haemostasis
ISSN 1538-7933 · eISSN 1538-7836 · Wiley-Blackwell Publishing Ltd · ENGLAND · Monthly · Founded 2003
Journal of Thrombosis and Haemostasis: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 5.18; hybrid open access; APC about USD 3,750; median 120 days to acceptance (155 articles, last 24 months); community-reported acceptance: fairly hard; 529 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Thrombosis and Haemostasis is published by Wiley-Blackwell Publishing Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Blood Coagulation and Thrombosis Mechanisms, Venous Thromboembolism Diagnosis and Management and Platelet Disorders and Treatments, together about 43.5% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Thrombosis and Haemostasis (JTH) is the official journal of the International Society on Thrombosis and Haemostasis. The mission of JTH is to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology through the diffusion and exchange of information and ideas within the international research community. The Journal publishes high quality, original research reports, state of the art reviews, brief reports, case reports, invited commentaries on publications in the Journal, forum articles, correspondence and announcements. Editors invite both fundamental and clinical contributions.These include basic manuscripts on blood coagulation and fibrinolysis, proteins and reactions, blood platelets, and the interaction of all these components with other biological systems such as, but not limited to, the vessel wall, blood cells, and invading organisms. Clinical manuscripts can cover a wide variety of topics including venous thrombosis and arterial disease, plus hemophilia and other bleeding disorders, as well as platelet diseases. The subject area of clinical manuscripts can range from etiology to diagnostics, prognosis, prevention, and treatment.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief Suzanne CannegieterPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 38, Netherlands 20, Canada 14, Italy 10, United Kingdom 6 (121 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Coagulation and Thrombosis MechanismsMedicine16.1%
- Venous Thromboembolism Diagnosis and ManagementMedicine13.8%
- Platelet Disorders and TreatmentsMedicine13.7%
- Hemophilia Treatment and ResearchMedicine7.8%
- Blood properties and coagulationMedicine6.3%
- Atrial Fibrillation Management and OutcomesMedicine5.6%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine4.7%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Hematology | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.18LetPub ·
- Impact factor (publisher)
- 5.2Publisher website ·
- CiteScore 2026-06
- 8.8LetPub ·
- CiteScore (publisher)
- 8.8Publisher website ·
- SJR 2026-06
- 2.05LetPub ·
- SNIP 2026-06
- 1.68LetPub ·
- h-index
- 154LetPub ·
- h-index
- 246OpenAlex ·
- i10-index
- 6,479OpenAlex ·
- 2-year mean citedness
- 3.83OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 30.98%LetPub ·
Volume
- Articles per year
- 332LetPub ·
Articles by year OpenAlex count · 12,232 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 361 | 153 | 154 |
| 2025 | 529 | 354 | 1,459 |
| 2024 | 395 | 390 | 3,307 |
| 2023 | 540 | 540 | 7,909 |
| 2022 | 315 | 304 | 5,002 |
| 2021 | 439 | 425 | 10,870 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
120 daysMedian, submission to acceptance · P25–P75 74 days – 165 days
- Acceptance to online
- median 8 days (134 articles)
- Submission to online
- median 142 days
- Sample
- 155 articles with submission and acceptance dates (961 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to acceptance
- 105 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,750 / EUR 3,510 / GBP 3,000 / JPY 465,110 | — | — | |
| Publisher website | USD 3,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
- Not considered
- conflict of interest; ethics; license; peer review
Article types accepted22, with length limits
- brief reportshould be combined. The word count for Brief Reports should be kept to 2000 words for the main body of the text, with up to 30 references andmain text ≤ 2,000 words
- case reporte Editors-in-Chief prior to submission. Case Reports Case reports providing new pathophysiological or clinical management insights should be kept to 1500 words …main text ≤ 1,500 words
- educational reviewsEducational reviews aim to educate newcomers in the field on various clinical and basic science topics using relatively short but figure-dense reviews.Length not stated
- forumContributions can have the following formats: Original Article, Brief Report, Case Report, Review Article, Forum, Historical Sketch, Letter to the Editor, Resea…Length not stated
- guest editorialContributions are also accepted in the following formats by invitation only: JTH Commentary, JTH in Clinic, ISTH Guidance and Guidelines, ISTH SSC Communication…Length not stated
- historical sketchContributions can have the following formats: Original Article, Brief Report, Case Report, Review Article, Forum, Historical Sketch, Letter to the Editor, Resea…Length not stated
- hypothesisReview Articles Review articles will generally be solicited, but we also welcome unsolicited reviews on timely subjects. Review articles should be fewer than 50…Length not stated
- isth guidance and guidelinesContributions are also accepted in the following formats by invitation only: JTH Commentary, JTH in Clinic, ISTH Guidance and Guidelines, ISTH SSC Communication…Length not stated
- isth ssc communicationContributions are also accepted in the following formats by invitation only: JTH Commentary, JTH in Clinic, ISTH Guidance and Guidelines, ISTH SSC Communication…Length not stated
- jth commentaryContributions are also accepted in the following formats by invitation only: JTH Commentary, JTH in Clinic, ISTH Guidance and Guidelines, ISTH SSC Communication…Length not stated
- jth in clinicContributions are also accepted in the following formats by invitation only: JTH Commentary, JTH in Clinic, ISTH Guidance and Guidelines, ISTH SSC Communication…Length not stated
- letterReview Articles Review articles will generally be solicited, but we also welcome unsolicited reviews on timely subjects. Review articles should be fewer than 50…main text ≤ 1,500 words
- letter to the editorContributions can have the following formats: Original Article, Brief Report, Case Report, Review Article, Forum, Historical Sketch, Letter to the Editor, Resea…Length not stated
- methods paperReview Articles Review articles will generally be solicited, but we also welcome unsolicited reviews on timely subjects. Review articles should be fewer than 50…Length not stated
- methods papersWe suggest that papers describing a new (laboratory) method to be directly submitted to RPTH unless the paper describes a unique approach rather than an improve…Length not stated
- obituaryContributions can have the following formats: Original Article, Brief Report, Case Report, Review Article, Forum, Historical Sketch, Letter to the Editor, Resea…Length not stated
- original articleReview Articles Review articles will generally be solicited, but we also welcome unsolicited reviews on timely subjects. Review articles should be fewer than 50…main text ≤ 5,000 words
- protocolReview Articles Review articles will generally be solicited, but we also welcome unsolicited reviews on timely subjects. Review articles should be fewer than 50…Length not stated
- protocol papersWe will consider papers describing a protocol for a clinical study, but only when the protocol paper describes a novelty in approach or the analysis plan, or wh…Length not stated
- research letterContributions can have the following formats: Original Article, Brief Report, Case Report, Review Article, Forum, Historical Sketch, Letter to the Editor, Resea…Length not stated
- reviewReview Articles Review articles will generally be solicited, but we also welcome unsolicited reviews on timely subjects. Review articles should be fewer than 50…main text ≤ 5,000 words
- review articleReview Articles Review articles will generally be solicited, but we also welcome unsolicited reviews on timely subjects. Review articles should be fewer than 50…main text ≤ 5,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints
- Authorship Authorship
Author rights to reuse work Model summary
Please note that all authors must fulfill authorship criteria as outlined in the recommendations of the International Committee of Medical Journal Editors (ICMJW). In short, all authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising i…
Source ↗Publisher website ·- Conflicts of interest
Competing interests and generative AI declaration required Model summary
A Competing Interests statement (Declaration Tool) and a declaration of generative AI use is provided, even if the authors have no competing interests or use of generative AI to declare (in which case this should be stated explicitly)
Source ↗Publisher website ·- Publication ethics
Study reporting checklists required when applicable Model summary
Study checklists, if applicable (e.g., CONSORT, STROBE, PRISMA, or TRIPOD)
Source ↗Publisher website ·- License & copyright Copyright
Journal Publishing Agreement required upon acceptance Model summary
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see https://www.elsevier.com/about/policies/copyright more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. Subscribers may reproduce tab…
Source ↗Publisher website ·- Open access Open Access
Article Publishing Charge (APC): USD 3,990 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·- Peer review
Original unpublished research required for certain categories Model summary
Submitted manuscripts in the categories of Original Article, Brief Report, Research Letter and Case Report must describe original, unpublished research that is not under consideration for publication elsewhere.
Source ↗Publisher website ·- Plagiarism
Similarity Check plagiarism screening Model summary
To verify originality, your article may be checked by the originality detection service Similarity Check
Source ↗Publisher website ·- Preprints
Preprint policy: preprint versions allowed, not prior publication, must be disclosed Model summary
Draft versions of articles on preprint servers such as bioRxiv and medRxiv are allowed and will not count as prior publication. However, this must be fully disclosed during submission.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 2003
- ISSN
- 1538-7933
- Electronic ISSN
- 1538-7836
- Society / sponsor
- International Society on Thrombosis and Haemostasis
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Thrombosis and Haemostasis
What CAS zone is Journal of Thrombosis and Haemostasis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Thrombosis and Haemostasis is in Zone 1 of Medicine, and in Zone 2 of the minor category Hematology / Peripheral Vascular Disease; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Thrombosis and Haemostasis?
The latest impact factor listed by LetPub is 5.18; CiteScore 8.8, h-index 246.
How long does peer review take at Journal of Thrombosis and Haemostasis?
Based on the dates recorded on 155 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 74–165 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Thrombosis and Haemostasis?
According to the journal's author guidelines: Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Thrombosis and Haemostasis based?
Of the 121 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (38), Netherlands (20) and Canada (14). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Thrombosis and Haemostasis?
According to LetPub and DOAJ records, Journal of Thrombosis and Haemostasis is indexed in SCIE and Scopus.
Is Journal of Thrombosis and Haemostasis open access, and what is the APC?
Journal of Thrombosis and Haemostasis is a hybrid journal. For open-access publication: APC about USD 3,750.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .